Your browser doesn't support javascript.
loading
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Fathi, Mehrdad; Bahmanpour, Simin; Barshidi, Asal; Rasouli, Hossein; Karoon Kiani, Fariba; Mahmoud Salehi Khesht, Armin; Izadi, Sepideh; Rashidi, Bentolhoda; Kermanpour, Shiva; Mokhtarian, Roya; Karpisheh, Vahid; Hassannia, Hadi; Mohammadi, Hamed; Jalili, Ali; Jadidi-Niaragh, Farhad.
Afiliação
  • Fathi M; Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran; Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran; Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Bahmanpour S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Barshidi A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rasouli H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karoon Kiani F; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mahmoud Salehi Khesht A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Izadi S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rashidi B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kermanpour S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mokhtarian R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karpisheh V; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hassannia H; Immunogenetic Research Center, Faculty of Medicine and Amol Faculty of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
  • Mohammadi H; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Jalili A; Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran; Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: Ali130@gmail.com.
  • Jadidi-Niaragh F; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: jadidif@tbzmed.ac.ir.
Int Immunopharmacol ; 101(Pt A): 108288, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34710844
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Protocolos de Quimioterapia Combinada Antineoplásica / Subunidade alfa do Fator 1 Induzível por Hipóxia / Sistemas de Liberação de Fármacos por Nanopartículas / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Protocolos de Quimioterapia Combinada Antineoplásica / Subunidade alfa do Fator 1 Induzível por Hipóxia / Sistemas de Liberação de Fármacos por Nanopartículas / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article